Latest News about VRTX
Recent news which mentions VRTX
Here's What Investors Need to Know About Vertex Pharmaceuticals and CRISPR Therapeutics' Big Day at the FDA
November 03, 2023
From Motley Fool
One Month Ahead of its Most Crucial Moment Ever, Should You Buy CRISPR Therapeutics?
November 02, 2023
From Motley Fool
Crispr Therapeutics’ stock soars as FDA-panel meeting raises hopes sickle-cell-disease drug will be approved
November 01, 2023
From MarketWatch
Here's How Much $100 Invested In Vertex Pharmaceuticals 10 Years Ago Would Be Worth Today
November 01, 2023
Tickers
VRTX
From Benzinga
Gene Therapy Could Be On the Cusp of a Major Breakthrough, but Investors May Have to Remain Patient
October 30, 2023
From Motley Fool
From Motley Fool
From InvestorPlace
Questions Surround Vertex/CRISPR's Sickle Cell Gene Therapy As FDA AdComm Meeting Approaches
October 27, 2023
From Benzinga
Got $1,000? 3 Growth Stocks to Buy That Could Double Your Money
October 27, 2023
From Motley Fool
2 Healthcare Stocks That Could Make You Richer
October 27, 2023
From Motley Fool
2 Top Healthcare Stocks Defying the Bear Market
October 26, 2023
From Motley Fool
From Motley Fool
2 Best Healthcare Stocks to Buy Right Now
October 26, 2023
From Motley Fool
Vertex Pharmaceuticals: Buy at the High?
October 26, 2023
From Motley Fool
3 Healthcare Stocks to Buy and Hold for the Next 10 Years
October 26, 2023
From Motley Fool
2 No-Brainer Growth Stocks to Buy Right Now
October 26, 2023
From Motley Fool
2 Fantastic Growth Stocks to Buy Hand Over Fist
October 26, 2023
From Motley Fool
3 Red-Hot Growth Stocks That Are Still Cheap Buys
October 25, 2023
From Motley Fool
The Best Stocks to Invest $5,000 In Right Now
October 24, 2023
From Motley Fool
3 Unstoppable Stocks to Buy Sooner Rather Than Later
October 22, 2023
From Motley Fool
A Look Into Vertex Pharmaceuticals Inc's Price Over Earnings
October 20, 2023
Tickers
VRTX
From Benzinga
3 Monster Stocks to Buy Without Any Hesitation
October 20, 2023
From Motley Fool
4 Ways to Grow $100,000 Into $1 Million for Retirement
October 19, 2023
From Motley Fool
From Benzinga
3 Gene Editing Stocks to Generate Super-Charged Gains
October 18, 2023
From InvestorPlace
Mixed Signals For CRISPR Therapeutics, Analyst Weighs Barriers, Potential Sales For Sickle Cell Therapy
October 17, 2023
From Benzinga
2 Healthcare Stocks Near 52-Week Highs Still Worth Buying
October 16, 2023
From Motley Fool
This Cathie Wood Stock Is Set to Soar 100%, Says Wall Street
October 16, 2023
From Motley Fool
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.